Clinical Trials Browser

Phase 1 × INDUSTRY × Advanced Malignancy × Clear all

NCT07123129 2026-01-30

A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors

Phase 1 Recruiting

Advanced Malignancy

NCT02978482 2021-08-18

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Phase 1 Completed

Advanced Malignancy